SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

News and Press

News Archive

 

April 24th 2018

 

Stem Cell Community Day in Düsseldorf



"Bioprocessing Technologies in Stem Cell Research: Perspectives on Process Design, Scale-Up, and Product Safety"

 

Organised by Eppendorf AG Bioprocess Center.

The Second International Stem Cell Community Day—A Review
On April 24, 2018, the second international Stem Cell Community Day took place in Düsseldorf, Germany. More than 150 participants from 16 countries—22 of them presenting a poster—attended, a solid growth in the number of attendees compared to the first Stem Cell Community Day in 2017. The event was fully dedicated to stem cell bioprocessing with many participants acknowledging that this format, “fills a gap in the European conference landscape”.


The program covered some of the most important challenges in stem cell bioprocessing today: Process design, scale-up, and product safety. After a warm welcome by the conference chair, Professor Joaquim Cabral from the University of Lisbon, nine speakers from academia and industry presented their latest results, concepts, and thoughts.


In his keynote lecture “Propelling hiPSC-cardiomyocyte and macrophage production forward” Robert Zweigerdt highlighted a further challenge on the route to the clinical use of hiPSC-derived cells - the production of high cell numbers. One part of the answer could be process mode optimization. Zweigerdt’s results showed how the cell yield can be increased by controlling process parameters like pH and glucose concentration and the concentrations of nutrients and byproducts in perfusion mode.


Carolin Halloin from the MHH won 1st place in the poster prize competition with her poster titled Chemically defined cardiomyogenic differentiation of human pluripotent stem cells in bioreactors, followed by Leopold König from TissUse GmbH, and Lucas-Sebastian Spitzhorn from the Heinrich Heine Uni  versity Hospital Duesseldorf.

 

 

 

 

 

 

 

 

 

 

 

 

Event Homepage

 

(Text and Images provided by EPPENDORF)

 

 

_______________________________________________________________________________________________

 

 

March 2018

 

TECHNOBEAT Meeting for Regenerative Medicine

 

 

From iPSCs to Translation

Weizmann Institute of Science, Israel

 

The TECHNOBEAT consortium, under the lead of MHH and project partner KADIMASTEM, hosted the first official satellite meeting at the renowned Weizmann Institute of Science. The half-day event was attended by the wider scientific community engaged in regenerative science, biomedical research and (pre-)clinical translation.

 

___________________________________________________

 

 

TECHNOBEAT Consortium meets for 3rd General Assembly

 

Hosted by the Consortium Partner KADIMASTEM on March 6th-7th, 2018 the event focused on progress of the work packages since the first periodic report was submitted in August 2017. The principal investigators presented the general overview of their work packages, supplemented by an in-depth overview of data and results to date by the researchers.

Further to the discussion of results, upcoming activities and additional points of intersection and cooperation were identified and agreed on.

As last year, two members of the TECHNOBEAT Scientific Advisory Board also attended the GA and gave their input and advice during the session "Bioprocessing technologies for hiPSC: current status".

 

 

 

______________________________________________________________________________________________

 

 

March 2017

 

 

 

TECHNOBEAT Consortium meets for 2nd General Assembly

 

Hosted by the Consortium Partner DASGIP-Eppendorf on February 16th-17th, 2017 the event focused on progress of the first 12 months of work. The principal investigators presented the general overview of their work packages, supplemented by an in-depth overview of data and results to date by the researchers.

Further to the discussion of results, upcoming activities and additional points of intersection and cooperation were identified and agreed on.

 

A highlight was the presence of two members of the TECHNOBEAT Scientific Advisory Board who also held expert advisor key note speeches.

Prof. Loren J. Field, Indiana University School of Medicine
Current status of cell based heart repair

Prof. Paul J. Fairchild, Sir William Dunn School of Pathology, University of Oxford
Immunological barriers to cell replacement therapy in animal models and prospects for the induction of immunological tolerance

 

_______________________________________________________________________________________________

 

 

March 2016

 

 

 

TECHNOBEAT Consortium convenes first General Assembly Meeting

 

The kick-off event was conducted on March 3rd-4th, 2016 in Salzburg, Austria hosted by the Consortium Partner Paracelsus Medizinische Privatuniversität (PMU). The key focus of the meeting was to strengthen pre-established ties of the network, to define and resolve regulatory, organisational and practical issues, and to define the details of project tasks at hand. The work package leaders presented the upcoming activities in detail and discussed any potential challenges.

 

Subsequently, the inaugural gathering of TECHNOBEAT’s Steering committee was conducted to prepare and plan, thereby setting a positive, uniting tone for the operating mode within the consortium. Overall the kick-off helped partners to get to know each other’s strengths and capabilities, to foster the productive working relationships and to enhance communication networks.